Streetbeat News

Products Services

RMD

The Canada Sleep Apnea Devices Market is projected to grow from USD 338.54 million in 2023 to USD 465.53 million by 2029, with a CAGR of 5.41%. Key players include Braebon Medical, VitalAire, FPM Solutions, SomnoMed, and ResMed.

Portfolio Pulse from

December 04, 2024 | 9:30 am

BP

SHEL

Bangladesh has approved Shell, BP, Aramco, and Glencore as suppliers of spot LNG to increase competition and reduce costs.

Portfolio Pulse from

December 04, 2024 | 9:30 am

SHY

Shorter duration ETFs are currently favorable due to potential inflationary effects from Trump's policies, which may necessitate higher interest rates. SHY, while addressing this thesis, may not be optimal due to its moderate duration and expense ratio compared to alternatives like ISTB and FLOT.

Portfolio Pulse from

December 04, 2024 | 9:30 am

SON

Sonoco Products Company has completed its acquisition of Eviosys, enhancing its position as a global leader in metal food and aerosol can manufacturing. This acquisition is part of Sonoco's strategy to transform its portfolio.

Portfolio Pulse from

December 04, 2024 | 9:15 am

CHAT

The S&P 500 has seen a significant rise of 28% this year, surpassing its average annual return. An AI-focused ETF is highlighted as a promising investment during this bull market.

Portfolio Pulse from

December 04, 2024 | 9:15 am

META

Meta Platforms Inc plans to use nuclear power to meet the electricity demands of its AI data centers by the 2030s. The company has issued a request for proposals to develop up to four gigawatts of nuclear power capacity.

Portfolio Pulse from

December 04, 2024 | 9:00 am

ILMN

Synaffix has licensed its metal-free click chemistry technology to Illumina for use in next-generation DNA sequencing products. This agreement allows Illumina access to Synaffix's patent portfolio, potentially enhancing Illumina's NGS offerings.

Portfolio Pulse from

December 04, 2024 | 8:45 am

NNOMF

Nano One has provided an update on its alliance with Worley, highlighting the economic advantages of its One-Pot process for LFP cathode production. A detailed pre-license package is now available for target customers.

Portfolio Pulse from

December 04, 2024 | 8:30 am

NVAX

Novavax is selling its Czech manufacturing unit to Novo Nordisk for $200 million. The proceeds will be used to support Novavax's vaccine pipeline.

Portfolio Pulse from

December 04, 2024 | 8:30 am